Skip to main content

Hormonal Regulation of Energy Balance and Energy Stores

  • Chapter
  • First Online:
Bariatric Endocrinology
  • 874 Accesses

Abstract

Adipose tissue sits at the crossroads of metabolism. It actively participates in the day-to-day regulation of energy balance, and it is the largest reservoir of energy for long-term needs. The human body is designed to sense its current energy status. Fuel sensors are located in the abdominal cavity along the digestive tract but also in adipose tissue. Afferent signals from these sensors reach the central nervous system in the form of neural and hormonal inputs. The brain directs action to maintain a steady intake of nutrients and energy.

An overarching principle is that there are regulatory and counter-regulatory systems which are constantly operating, and the ratio of them is what determines the outcome. An example of this is the ratio of insulin to glucagon in the venous drainage of the pancreas, which determines the response of the liver acutely. Another example is the leptin to adiponectin ratio in the venous drainage of intra-abdominal (visceral) adipose tissue, which signals the liver and brain on the status of energy stores and adipose tissue function.

Constant fuel signaling allows the body access to nutrients. When access to nutrients is not possible, the body engages metabolic pathways to compensate. Long-term derangements of fuel acquisition cause profound alterations in the signaling pathways and allow the body to survive longer. Both anorexic diseases at one extreme and obesity on the other are characterized by changes from normal physiology. In the case of obesity, for example, there is a significant rise in the leptin to adiponectin ratio. This signals the brain that there are excess calories in storage and that adipose tissue function is compromised. Understanding these metabolic relationships allows for the development of targeted treatments for chronic diseases of metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Reading List

  • Abu-Hamdah R, Rabiee A, Meneilly GS, Shannon RP, Andersen DK, Elahi D. Clinical review: the extrapancreatic effects of glucagon-like peptide-1 and related peptides. J Clin Endocrinol Metab. 2009;94(6):1843–52. Epub 2009/04/02.

    Article  CAS  Google Scholar 

  • Bays HE, Gonzalez-Campoy JM. Adiposopathy. In: Friedberg E, Castrillon DH, Galindo RL, Wharton K, editors. New-Opathies: World Scientific; 2012. p. 105–68.

    Google Scholar 

  • Breen DM, Rasmussen BA, Cote CD, Jackson VM, Lam TK. Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes. 2013;62(9):3005–13. Epub 2013/08/24.

    Article  CAS  Google Scholar 

  • Broeders EP, Vijgen GH, Havekes B, Bouvy ND, Mottaghy FM, Kars M, et al. Thyroid hormone activates brown adipose tissue and increases non-shivering thermogenesis—a cohort study in a Group of Thyroid Carcinoma Patients. PLoS One. 2016;11(1):e0145049. Epub 2016/01/20.

    Article  Google Scholar 

  • Brubaker PL. Minireview: update on incretin biology: focus on glucagon-like peptide-1. Endocrinology. 2010;151(5):1984–9. Epub 2010/03/23.

    Article  CAS  Google Scholar 

  • Cantini G, Di Franco A, Mannucci E, Luconi M. Is cleaved glucagon-like peptide 1 really inactive? Effects of GLP-1(9–36) on human adipose stem cells. Mol Cell Endocrinol. 2017;439:10–5. Epub 2016/10/30.

    Article  CAS  Google Scholar 

  • Chakraborti CK. Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesity. World J Diabetes. 2015;6(15):1296–308. Epub 2015/11/12.

    Article  Google Scholar 

  • Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C. Regulation of adipocyte formation by GLP-1/GLP-1R signaling. J Biol Chem. 2012;287(9):6421–30. Epub 2011/12/31.

    Article  CAS  Google Scholar 

  • D’Aquila T, Hung YH, Carreiro A, Buhman KK. Recent discoveries on absorption of dietary fat: presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes. Biochim Biophys Acta. 2016;1861(8 Pt A):730–47. Epub 2016/04/25.

    Article  Google Scholar 

  • DePaoli AM. 20 years of leptin: leptin in common obesity and associated disorders of metabolism. J Endocrinol. 2014;223(1):T71–81. Epub 2014/06/29.

    Article  CAS  Google Scholar 

  • Esfahani M, Movahedian A, Baranchi M, Goodarzi MT. Adiponectin: an adipokine with protective features against metabolic syndrome. Iranian J Basic Med Sci. 2015;18(5):430–42. Epub 2015/07/01.

    Google Scholar 

  • Farooqi IS, O’Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol. 2014;223(1):T63–70. Epub 2014/09/19.

    Article  CAS  Google Scholar 

  • Glasow A, Bornstein SR. Leptin and the adrenal gland. Eur J Clin Investig. 2000;30(Suppl 3):39–45. Epub 2001/04/03.

    Article  CAS  Google Scholar 

  • Gurriaran-Rodriguez U, Al-Massadi O, Roca-Rivada A, Crujeiras AB, Gallego R, Pardo M, et al. Obestatin as a regulator of adipocyte metabolism and adipogenesis. J Cell Mol Med. 2011;15(9):1927–40. Epub 2010/10/30.

    Article  CAS  Google Scholar 

  • Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a systematic review and mixed-treatment comparison analysis. Diabetes Obes Metab. 2017;19(4):524–36. Epub 2016/12/17.

    Article  CAS  Google Scholar 

  • Kargi AY, Iacobellis G. Adipose tissue and adrenal glands: novel pathophysiological mechanisms and clinical applications. Int J Endocrinol. 2014;2014:614074. Epub 2014/07/16.

    Article  Google Scholar 

  • Kawwass JF, Summer R, Kallen CB. Direct effects of leptin and adiponectin on peripheral reproductive tissues: a critical review. Mol Hum Reprod. 2015;21(8):617–32. Epub 2015/05/13.

    Article  CAS  Google Scholar 

  • Lacquaniti A, Donato V, Chirico V, Buemi A, Buemi M. Obestatin: an interesting but controversial gut hormone. Ann Nutr Metab. 2011;59(2–4):193–9. Epub 2011/12/14.

    Article  CAS  Google Scholar 

  • Liao YC, Liang KW, Lee WJ, Lee WL, Lee IT, Wang JS, et al. Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X. Biomarkers: Biochem Indicators Exposure Response Susceptibility Chem. 2013;18(1):44–50. Epub 2012/10/17.

    Article  CAS  Google Scholar 

  • Liu R, Li L, Chen Y, Yang M, Liu H, Yang G. Effects of glucagon-like peptide-1 agents on left ventricular function: systematic review and meta-analysis. Ann Med. 2014;46(8):664–71. Epub 2014/08/20.

    Article  CAS  Google Scholar 

  • Lopez-Jaramillo P, Gomez-Arbelaez D, Lopez-Lopez J, Lopez-Lopez C, Martinez-Ortega J, Gomez-Rodriguez A, et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Invest. 2014;18(1):37–45. Epub 2014/11/13.

    CAS  Google Scholar 

  • Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, et al. Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab. 2011;301(4):E567–84. Epub 2011/07/28.

    Article  CAS  Google Scholar 

  • Muller MJ, Enderle J, Bosy-Westphal A. Changes in energy expenditure with weight gain and weight loss in humans. Curr Obes Rep. 2016;5(4):413–23. Epub 2016/10/16.

    Article  Google Scholar 

  • Nayak S, Bhaktha G, Mohammed S. Adiponectin in diabetic subjects without any micro- or macrovascular complications: a review. J Diabetes Sci Technol. 2015;9:1160. Epub 2015/04/26

    Article  CAS  Google Scholar 

  • Nerup N, Ambrus R, Lindhe J, Achiam MP, Jeppesen PB, Svendsen LB. The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: a systematic review. Microcirculation. 2017; Epub 2017/03/08.

    Google Scholar 

  • Obregon MJ. Adipose tissues and thyroid hormones. Front Physiol. 2014;5:479. Epub 2015/01/08.

    Article  Google Scholar 

  • Park JT, Yoo TH, Kim JK, Oh HJ, Kim SJ, Yoo DE, et al. Leptin/adiponectin ratio is an independent predictor of mortality in nondiabetic peritoneal dialysis patients. Perit Dial Int. 2013;33(1):67–74. Epub 2012/08/03.

    Article  CAS  Google Scholar 

  • Pruszynska-Oszmalek E, Szczepankiewicz D, Hertig I, Skrzypski M, Sassek M, Kaczmarek P, et al. Obestatin inhibits lipogenesis and glucose uptake in isolated primary rat adipocytes. J Biol Regul Homeost Agents. 2013;27(1):23–33. Epub 2013/03/16.

    CAS  PubMed  Google Scholar 

  • Sayegh AI. The role of cholecystokinin receptors in the short-term control of food intake. Prog Mol Biol Transl Sci. 2013;114:277–316. Epub 2013/01/16.

    Article  CAS  Google Scholar 

  • Seim I, Walpole C, Amorim L, Josh P, Herington A, Chopin L. The expanding roles of the ghrelin-gene derived peptide obestatin in health and disease. Mol Cell Endocrinol. 2011;340(1):111–7. Epub 2011/04/05.

    Article  CAS  Google Scholar 

  • Sun F, Chai S, Li L, Yu K, Yang Z, Wu S, et al. Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis. J Diabetes Res. 2015;2015:157201. Epub 2015/02/18.

    Article  Google Scholar 

  • Tang SQ, Jiang QY, Zhang YL, Zhu XT, Shu G, Gao P, et al. Obestatin: its physicochemical characteristics and physiological functions. Peptides. 2008;29(4):639–45. Epub 2008/03/08.

    Article  CAS  Google Scholar 

  • Vega GL, Grundy SM. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. J Obes. 2013;2013:409679. Epub 2013/03/28.

    Article  Google Scholar 

  • Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ. 2012;344:d7771. Epub 2012/01/13.

    Article  Google Scholar 

  • Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science. 2005;310(5750):996–9. Epub 2005/11/15.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Michael Gonzalez-Campoy .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gonzalez-Campoy, J.M. (2019). Hormonal Regulation of Energy Balance and Energy Stores. In: Gonzalez-Campoy, J., Hurley, D., Garvey, W. (eds) Bariatric Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-95655-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95655-8_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95653-4

  • Online ISBN: 978-3-319-95655-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics